Athira Pharma (ATHA)
NASDAQ:ATHA
US Market

Athira Pharma (ATHA) Stock Investors

284 Followers
Based on 610,515 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ATHA
On average, investors allocate 2.87% of their portfolios to ATHA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 610,515 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ATHA

0.6%
Last 7
Days
9.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ATHA, out of 610,515 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ATHA Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
3.49%
$3.71
Opened
5.87%
$3.29
Increased
1.34%
$3.94
Reduced
0.00%
$3.08
Based on the activity of 11,658 investors who made their portfolios public
The table shows changes in ATHA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ATHA Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Zoom Video Communications
3.39%
-0.51%
-1.79%
$23.25B
Technology
Moderna
6.09%
+0.24%
+1.51%
$66.56B
Healthcare
Tilray
4.82%
-0.13%
-0.86%
$1.97B
Basic Materials
DocuSign
3.07%
-0.13%
-1.46%
$13.14B
Technology
Abbott Labs
3.82%
-0.24%
+0.49%
$194.91B
Healthcare
Virgin Galactic Holdings
4.40%
-0.65%
-0.73%
$1.67B
Technology
Gilead Sciences
4.33%
-0.29%
-0.72%
$105.98B
Healthcare
General Electric
5.77%
-0.11%
+2.22%
$89.56B
Industrial Goods
Crispr Therapeutics AG
3.97%
-0.01%
-0.53%
$4.33B
Healthcare
Pinterest
4.01%
+0.17%
-1.28%
$18.51B
Technology
Based on the activity of 610,515 active portfolios
Open your Smart Portfolio

ATHA Investor Analysis

ATHA investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
19.3%
of ATHA holders
are under 35
Average Segment Performance
Average P/E Ratio1.83
Beta4.80
Dividend Yield5.23%
ATHA investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
50.9%
of ATHA holders
are between 35–55
Average Segment Performance
Average P/E Ratio0.49
Beta1.09
Dividend Yield5.04%
ATHA investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
29.8%
of ATHA holders
are over 55
Average Segment Performance
Average P/E Ratio0.75
Beta1.00
Dividend Yield4.33%
Overview of age group and performance of ATHA stock investors
See who invests in ATHA according to age group and performance.

FAQ

How many retail Investors hold ATHA?
<0.1% of TipRank’s retail investors hold ATHA in their portfolios.
    What is ATHA Investor Sentiment?
    ATHA’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of ATHA in the last 7 days?
      ▲ 0.6% of TipRank’s retail investors changed their holding of ATHA in the last 7 days.
        What percentage of retail investors changed their holding of ATHA in the last 30 days?
        ▲ 9.2% of TipRank’s retail investors changed their holding of ATHA in the last 30 days.
          What is the average age of retail investors who hold ATHA?
          The average age of ATHA Holders is between 35–55.
            What other stocks have ATHA investors also bought?
            ATHA Investors also bought ZM, MRNA, TLRY, DOCU, ABT, SPCE, GILD, GE, CRSP, PINS.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AAgilent
              ALGNAlign Tech
              ALNYAlnylam Pharma
              AMRNAmarin
              BAXBaxter International

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis